We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$11.9B
AUM Growth
+$1.64B
Cap. Flow
+$3.17B
Cap. Flow %
26.56%
Top 10 Hldgs %
6.6%
Holding
3,409
New
939
Increased
912
Reduced
776
Closed
491

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$94M
2
EXPE icon
Expedia Group
EXPE
+$81.1M
3
AIG icon
American International
AIG
+$68.7M
4
AMZN icon
Amazon
AMZN
+$68M
5
CRBG icon
Corebridge Financial
CRBG
+$65.9M

Top Sells

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$94.3M
2
FERG icon
Ferguson
FERG
+$70.5M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$66.2M
4
HIG icon
Hartford Financial Services
HIG
+$65.2M
5
MTB icon
M&T Bank
MTB
+$60.7M

Sector Composition

Rank Sector Weight
1 Financials 22.64%
2 Technology 16.18%
3 Consumer Discretionary 11.16%
4 Industrials 10.33%
5 Healthcare 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MXL icon
1301
MaxLinear
MXL
$6.8B
$956K 0.01%
29,300
-470,388
-94% -$17.4M
CDW icon
1302
CDW
CDW
$17B
$952K 0.01%
+6,100
New +$1.05M
CORT icon
1303
Corcept Therapeutics
CORT
$12B
$950K 0.01%
+37,068
New +$992K
EEM icon
1304
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$950K 0.01%
200,000
– –
CHAA
1305
DELISTED
Catcha Investment Corp
CHAA
$950K 0.01%
95,980
+20,100
+26% +$199K
IR icon
1306
Ingersoll Rand
IR
$33.7B
$948K 0.01%
+21,909
New +$1.03M
NGM
1307
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$946K 0.01%
+72,382
New +$1.1M
VRDN icon
1308
Viridian Therapeutics
VRDN
$2.67B
$945K 0.01%
+52,623
New +$946K
EPC icon
1309
Edgewell Personal Care
EPC
$1.31B
$942K 0.01%
+25,200
New +$983K
FTAA
1310
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$942K 0.01%
94,850
+15,642
+20% +$154K
FORM icon
1311
FormFactor
FORM
$9.17B
$941K 0.01%
37,600
+31,400
+506% +$1.02M
FRSG
1312
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$938K 0.01%
95,500
-13,303
-12% -$131K
PECO icon
1313
Phillips Edison & Co
PECO
$5.24B
$937K 0.01%
33,400
-253,449
-88% -$8.33M
IPVF
1314
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$937K 0.01%
95,310
– –
ASLE icon
1315
AerSale
ASLE
$279M
$936K 0.01%
50,500
+29,200
+137% +$540K
MIRM icon
1316
Mirum Pharmaceuticals
MIRM
$6.14B
$936K 0.01%
+44,540
New +$1.07M
UBSI icon
1317
United Bankshares
UBSI
$6.62B
$936K 0.01%
+26,176
New +$976K
LMACA
1318
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$935K 0.01%
94,105
+20,865
+28% +$206K
APPF icon
1319
AppFolio
APPF
$7.04B
$932K 0.01%
8,900
+1,800
+25% +$184K
CCRN
1320
DELISTED
Cross Country Healthcare
CCRN
$931K 0.01%
+32,842
New +$844K
SLF icon
1321
Sun Life Financial
SLF
$45.4B
$931K 0.01%
23,400
+11,400
+95% +$511K
MYOV
1322
DELISTED
Myovant Sciences Ltd.
MYOV
$930K 0.01%
+51,847
New +$828K
BLUA
1323
DELISTED
BlueRiver Acquisition Corp.
BLUA
$926K 0.01%
+93,370
New +$922K
AMPH icon
1324
Amphastar Pharmaceuticals
AMPH
$916M
$924K 0.01%
32,900
+25,100
+322% +$820K
KLAQ
1325
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
$924K 0.01%
93,466
+38,755
+71% +$382K
51 52
53
54 55

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Schonfeld Strategic Advisors held 3,409 positions worth $11.9B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Schonfeld Strategic Advisors deployed $3.17B of net new capital in Q3 2022, opening 939 new positions and adding to 912 existing holdings. Its largest new stake was Corebridge Financial: 3,204,461 shares worth $63.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gen Digital, an estimated $94.3M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2022 buy was Corebridge Financial: 3,204,461 shares worth $63.1M.
  • Schonfeld Strategic Advisors added most to Fidelity National Information Services in Q3 2022, an estimated $94M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2022 reduction was Gen Digital, cutting an estimated $94.3M.
  • Schonfeld Strategic Advisors fully exited UMB Financial in Q3 2022, selling an estimated $33.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 6.6% of its $11.9B portfolio in Q3 2022.
  • Schonfeld Strategic Advisors opened 939 new positions and closed 491 in Q3 2022.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $11.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.